596 related articles for article (PubMed ID: 27150293)
1. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
3. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
[TBL] [Abstract][Full Text] [Related]
5. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation for the Ablation of Prostate Cancer.
Karagiannis A; Varkarakis J
Curr Urol Rep; 2019 Sep; 20(10):63. PubMed ID: 31478109
[TBL] [Abstract][Full Text] [Related]
7. Focal irreversible electroporation as primary treatment for localized prostate cancer.
van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
[TBL] [Abstract][Full Text] [Related]
8. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
9. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
10. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.
Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):46-52. PubMed ID: 26458959
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.
Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK
PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263
[TBL] [Abstract][Full Text] [Related]
12. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
[TBL] [Abstract][Full Text] [Related]
13. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
[TBL] [Abstract][Full Text] [Related]
14. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
[TBL] [Abstract][Full Text] [Related]
15. [Irreversible electroporation. Current value for focal treatment of prostate cancer].
Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB;
Urologe A; 2015 Jun; 54(6):854-62. PubMed ID: 26024649
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
[TBL] [Abstract][Full Text] [Related]
17. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
Valerio M; Dickinson L; Ali A; Ramachandran N; Donaldson I; Freeman A; Ahmed HU; Emberton M
Contemp Clin Trials; 2014 Sep; 39(1):57-65. PubMed ID: 25072507
[TBL] [Abstract][Full Text] [Related]
18. Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial.
Wang H; Xue W; Yan W; Yin L; Dong B; He B; Yu Y; Shi W; Zhou Z; Lin H; Zhou Y; Wang Y; Shi Z; Ren S; Gao X; Wang L; Xu C
JAMA Surg; 2022 Aug; 157(8):693-700. PubMed ID: 35793110
[TBL] [Abstract][Full Text] [Related]
19. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.
Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB
World J Urol; 2017 Jan; 35(1):11-20. PubMed ID: 27147512
[TBL] [Abstract][Full Text] [Related]
20. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
